Trial Details
RECRUITINGBasic Information
| Clinical ID | c1003 |
|---|---|
| Identifier | NCT06651281 |
| Trial Title | Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative |
| Interventions | DRUG: Tulisokibart|DRUG: Placebo to tulisokibart |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | Bristol |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-11-25 |
|---|---|
| Primary Completion Date | 2037-12-17 |
| Completion Date | 2037-12-17 |